Stryker news
The WiseView Research desk's stories that name Stryker, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The SYK page →
- HeadlineSYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?
- HeadlineStryker to participate in the 2026 Jefferies Global Healthcare Conference
- HeadlineIt's Too Soon To Upgrade Stryker Corporation
- HeadlineCountdown to Stryker (SYK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
- HeadlineStryker completes acquisition of ZuriMED to enhance its shoulder offering
- HeadlineStryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- HeadlineStryker's Sonopet 3 Secures FDA Clearance to Improve Surgical Accuracy
- HeadlineStryker Enters Soft-Tissue Robotics With $400 Million CMR Deal
- HeadlineStryker launches Sonopet® 3, delivering greater power and precision in ultrasonic tissue removal
- HeadlineStryker: Q2 Recovery And Portfolio Expansion Strengthen The Operating Story
- CongressRo Khanna bought $1,001 - $15,000 of SYK
- CongressRo Khanna sold $15,001 - $50,000 of SYK
- CongressRo Khanna sold $1,001 - $15,000 of SYK
- HeadlineStryker announces leadership succession
- HeadlineStryker: This Dividend Aristocrat Is Finally Cheap Again
- HeadlineStryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSS
- HeadlineStryker to announce third quarter 2026 financial results
- CongressThomas Kean sold $1,001 - $15,000 of SYK
- CongressAlan Armstrong sold $15,001 - $50,000 of SYK
- CongressThomas Kean sold $1,001 - $15,000 of SYK
- CongressRo Khanna bought $15,001 - $50,000 of SYK
- CongressThomas Kean sold $15,001 - $50,000 of SYK
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.